Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pain, Postoperative 4Breast Neoplasms 4Liver Neoplasms 2Colonic Neoplasms 2Chronic Pain 2Carcinoma, Non-Small-Cell Lung 2Supratentorial Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostatic Neoplasms 1Postoperative Hemorrhage 1Pilonidal Sinus 1Pain 1Oropharyngeal Neoplasms 1Opioid-Related Disorders 1Nevus, Pigmented 1Neuroma 1Neuralgia 1Neoplasms 1Melanoma 1Malignant Pleural Neoplasm 1Lung Neoplasms 1Localised Prostate Cancer 1Leiomyoma 1Ileus 1Hordeolum 1Glioblastoma 1Eyelid Neoplasms 1Colorectal Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Ultrasonic Waves 1Tirzepatide 1Therapeutics 1Standard of Care 1Psilocybin 1Olanzapine 1Midazolam 1Lidocaine 1Educational Status 1Dosage Forms 1Buprenorphine, Naloxone Drug Combination 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Opioid-Related Disorders × Lidocaine × 1 year × Clear all
NCT07408193 2026-02-20

The Role of Coadministration of Lidocaine and Ketamine in Opioid-Refractory Chronic Cancer-Related Pain.

National and Kapodistrian University of Athens

Phase EARLY_PHASE1 Not yet recruiting
24 enrolled

Cancer Pain, Opioid-Related Disorders, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡